Dr. Xavier Bonet, Medical Director of Andrología Mallorca, participated as a speaker at the scientific meeting “Perovial: From Innovation to Clinical Practice”, held on 6 November 2026 in Madrid, where advances in the diagnosis and treatment of Peyronie’s disease were discussed.
On 6 November, Madrid hosted “Perovial: From Innovation to Clinical Practice”, a scientific meeting supported by IBSA that brought together national and international specialists in urology and andrology to share knowledge and clinical experience regarding the management of Peyronie’s disease.
The event, held at the NH Collection Madrid Eurobuilding Hotel, featured Dr. Xavier Bonet, Medical Director of Andrología Mallorca, who delivered a scientific presentation and participated in a roundtable discussion on initial clinical experience with emerging therapeutic approaches.
His participation reflects Andrología Mallorca’s commitment to scientific development, continuing medical education and improving specialised care in men’s sexual health.
Peyronie’s Disease: From Pathophysiology to Clinical Impact
During the meeting, Dr. Xavier Bonet delivered a presentation entitled “Peyronie’s Disease: From Pathophysiology to Clinical Impact”, focusing on the mechanisms underlying the condition and its effects on men’s sexual health.
Peyronie’s disease is characterised by the formation of fibrous tissue in the penis, which may cause curvature, pain during erections and difficulties with sexual intercourse.
Beyond its physical symptoms, the condition can significantly affect patients’ emotional well-being and quality of life.
Understanding its underlying mechanisms and progression is essential for accurate diagnosis and the development of an individualised treatment approach.
In this context, Dr. Bonet’s presentation contributed to the exchange of knowledge regarding the clinical aspects of Peyronie’s disease and the importance of specialist assessment.
New Perspectives in the Treatment of Peyronie’s Disease
One of the main objectives of the meeting was to discuss therapeutic options for acute-phase Peyronie’s disease, with particular attention to Perovial®, a hyaluronic acid-based treatment option.
Throughout the event, specialists reviewed international guideline recommendations, the scientific evidence presented on this treatment and practical considerations regarding its potential use in clinical practice.
The programme also included sessions addressing the role of ultrasound in diagnosis and follow-up, as well as the challenges associated with treating Peyronie’s disease in different healthcare settings.
These discussions highlighted the importance of continuing to evaluate available treatment options and tailoring clinical decisions to each patient’s individual characteristics and needs.
Dr. Xavier Bonet Participates in a Roundtable on Clinical Experience
In addition to his presentation, Dr. Xavier Bonet participated in the roundtable discussion “Initial Clinical Experience with Perovial® and Key Considerations for Implementation”, moderated by Dr. Javier Romero.
The session brought together specialists to share clinical experiences and discuss practical aspects of this therapeutic approach.
Topics included initial clinical outcomes, patient expectations, technical considerations, tolerability and follow-up recommendations.
This exchange of knowledge provided an opportunity to reflect on the importance of evaluating scientific evidence and sharing professional experiences before incorporating new therapeutic options into routine clinical practice.
Andrología Mallorca: Committed to Excellence in Men’s Sexual Health
At Andrología Mallorca, continuous professional development and participation in scientific meetings are essential components of our commitment to high-quality patient care.
The participation of our Medical Director, Dr. Xavier Bonet, as a speaker at this meeting provided an opportunity to contribute to the exchange of knowledge and the advancement of andrology.
The management of Peyronie’s disease requires specialised care, individualised assessment and an up-to-date understanding of available therapeutic approaches.
For this reason, Andrología Mallorca remains committed to evidence-based medicine, innovation and patient-centred healthcare.
Acknowledgements to IBSA
At Andrología Mallorca, we would like to express our sincere gratitude to IBSA for organising this scientific meeting and supporting education and knowledge exchange among specialists in urology and andrology.
We would also like to thank all speakers and participants for contributing to an event that encouraged the sharing of knowledge and clinical experience regarding current and future approaches to Peyronie’s disease.
We remain committed to providing specialised medical care based on scientific evidence, continuous education and a dedication to our patients’ health and well-being.
